Sonora Investment Management Group LLC Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sonora Investment Management Group LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,025 shares of the medical equipment provider’s stock after purchasing an additional 85 shares during the quarter. Sonora Investment Management Group LLC’s holdings in Intuitive Surgical were worth $535,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Mirador Capital Partners LP lifted its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $82,517,000. Exome Asset Management LLC raised its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp lifted its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock valued at $15,357,560 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Mizuho boosted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday. CICC Research assumed coverage on Intuitive Surgical in a research report on Monday. They set a “neutral” rating and a $550.00 price objective for the company. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Stock Performance

ISRG stock opened at $580.18 on Friday. The firm has a fifty day moving average price of $549.32 and a 200 day moving average price of $507.50. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market cap of $206.65 billion, a PE ratio of 90.51, a price-to-earnings-growth ratio of 5.52 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.